<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "JATS-journalpublishing1.dtd">
<article article-type="abstract" dtd-version="1.0" xml:lang="en" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">CC</journal-id>
<journal-id journal-id-type="nlm-ta">Cardiol Croat</journal-id>
<journal-title-group>
<journal-title>Cardiologia Croatica</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Cardiol. Croat.</abbrev-journal-title>
</journal-title-group>
<issn pub-type="ppub">1848-543X</issn>
<issn pub-type="epub">1848-5448</issn>
<publisher><publisher-name>Croatian Cardiac Society</publisher-name></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">CC 2022 18_5-6_131</article-id>
<article-id pub-id-type="doi">10.15836/ccar2023.131</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Extended Abstract</subject></subj-group>
</article-categories>
<title-group>
<article-title>New-onset heart failure symptoms caused by obstructive left atrial myxoma in a patient with a history of cryptogenic stroke two decades ago: a case report</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0888-5005</contrib-id><name><surname>Sopek Merka&#x0161;</surname><given-names>Ivana</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1">*</xref></contrib>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2329-2582</contrib-id><name><surname>Laku&#x0161;i&#x0107;</surname><given-names>Nenad</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib>
<contrib contrib-type="author"><name><surname>&#x0160;alkovi&#x0107;</surname><given-names>Jurica</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author"><name><surname>Hodalin</surname><given-names>Alen</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib>
<aff id="aff1"><label>1</label><institution>Special Hospital for Medical Rehabilitation Krapinske Toplice, Krapinske Toplice</institution>, <country country="hr">Croatia</country></aff>
<aff id="aff2"><label>2</label><institution content-type="dept">Faculty of Dental Medicine and Health Osijek</institution>, <institution>Josip Juraj Strossmayer University of Osijek</institution>, <addr-line>Osijek</addr-line>, <country country="hr">Croatia</country></aff>
<aff id="aff3"><label>3</label><institution content-type="dept">Faculty of Medicine Osijek</institution>, <institution>Josip Juraj Strossmayer University of Osijek</institution>, <addr-line>Osijek</addr-line>, <country country="hr">Croatia</country></aff>
<aff id="aff4"><label>4</label><institution>Magdalena Clinic for Cardiovascular Diseases, Krapinske Toplice</institution>, <country country="hr">Croatia</country></aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><label>*</label>ADDRESS FOR CORRESPONDENCE: Ivana Sopek Merka&#x0161;, Specijalna bolnica za medicinsku rehabilitaciju Krapinske Toplice, Gajeva 2, HR-49217 Krapinske Toplice, Croatia. / Phone: +385-49-383-100 / E-mail: <email xlink:href="ivana.sopek92@gmail.com">ivana.sopek92@gmail.com</email></corresp></author-notes>
<pub-date pub-type="epub-ppub"><month>04</month><year>2023</year></pub-date>
<volume>18</volume>
<issue>5-6</issue>
<fpage>131</fpage>
<lpage>131</lpage>
<history>
<date date-type="received"><day>15</day><month>03</month><year>2023</year></date>
<date date-type="accepted"><day>29</day><month>03</month><year>2023</year></date>
</history>
<permissions>
<copyright-year>2023</copyright-year>
<copyright-holder>Croatian Cardiac Society</copyright-holder>
</permissions>
<kwd-group kwd-group-type="author"><title>KEYWORDS: </title><kwd>myxoma</kwd><kwd>left atrium</kwd><kwd>mitral valve stenosis</kwd><kwd>heart failure</kwd><kwd>stroke</kwd></kwd-group>
</article-meta>
</front>
<body>
<p><bold>Introduction</bold>: Primary cardiac tumors are rare, with an incidence estimated to be approximately 100 times lower than that of secondary tumors (<xref ref-type="bibr" rid="r1"><italic>1</italic></xref>). Autopsy studies have indicated a prevalence of primary cardiac tumors ranging from 0.001% to 0.03% (<xref ref-type="bibr" rid="r1"><italic>1</italic></xref>). Myxomas are the most common type of primary cardiac tumor, accounting for 50-70% of cases (<xref ref-type="bibr" rid="r2"><italic>2</italic></xref>). Among myxomas, left atrial myxomas are the most frequent subtype, constituting about 75% of cases (<xref ref-type="bibr" rid="r2"><italic>2</italic></xref>). Although myxomas can occur in people of all ages and genders, they are more prevalent in women and typically arise in adults aged between 30 and 60 years. (<xref ref-type="bibr" rid="r1"><italic>1</italic></xref>) While the majority of myxomas occur sporadically (90%), some may be associated with genetic syndromes such as Carney complex or familial myxomatous syndrome (<xref ref-type="bibr" rid="r1"><italic>1</italic></xref>). Left atrial myxomas can cause various adverse outcomes due to multiple pathophysiological mechanisms. These include inducing intracardiac obstruction leading to symptoms of dyspnea, fatigue, and angina, embolization resulting in cerebral, limb, or organ ischemia, disrupting normal cardiac electrophysiology leading to arrhythmias, and inducing heart failure (<xref ref-type="bibr" rid="r1"><italic>1</italic></xref>, <xref ref-type="bibr" rid="r2"><italic>2</italic></xref>).</p>
<p><bold>Case report</bold>: We present a case of a 49-year-old woman who was referred for an echocardiographic examination due to newly developed symptoms of NYHA class II-III heart failure. The patient had a previous medical history of a stroke at the age of 32, and there is no documented medical evidence of a transthoracic echocardiogram or transesophageal echocardiogram being performed during the initial evaluation to assess for possible cardiac sources of embolism. She was discharged with a diagnosis of antiphospholipid syndrome and was on warfarin therapy for the next six years. However, this diagnosis was later excluded, and oral anticoagulant therapy was discontinued. Transthoracic echocardiography revealed a tumor mass within the left atrium, fixed to the interatrial septum, measuring approximately 2x4 cm (<xref ref-type="fig" rid="f1"><bold>Figure 1</bold></xref>). The mass dynamically moved and prolapsed into the left ventricle during diastole, causing obstruction of the mitral valve with hemodynamic parameters resembling severe mitral stenosis (peak gradient 20 mmHg, mean gradient 14 mmHg) and resulting in moderate pulmonary hypertension (pulmonary artery pressure around 60 mmHg). A cardiac surgical procedure was subsequently performed, during which the tumor mass was completely excised. The pathology report described the tumor as a myxoma.</p>
<fig id="f1" position="float" fig-type="figure"><label>FIGURE 1</label><caption><p>Visualization of a left atrium myxoma from the long parasternal axis view.</p></caption><graphic xlink:href="CC202218_5-6_131-f1"></graphic></fig>
</body>
<back>
<ref-list>
<title>LITERATURE</title>
<ref id="r1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raicea</surname><given-names>VC</given-names></name><name><surname>Suciu</surname><given-names>H</given-names></name><name><surname>Raicea</surname><given-names>AD</given-names></name><name><surname>Macarie</surname><given-names>GC</given-names></name><name><surname>Mezei</surname><given-names>T</given-names></name><name><surname>Maier</surname><given-names>MS</given-names></name></person-group>. <article-title>Giant left atrial myxoma - literature review and case presentation.</article-title> <source>Rom J Morphol Embryol</source>. <year>2021</year> April-June;<volume>62</volume>(<issue>2</issue>):<fpage>361</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.47162/RJME.62.2.02</pub-id><pub-id pub-id-type="pmid">35024724</pub-id></mixed-citation></ref>
<ref id="r2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoffmeier</surname><given-names>A</given-names></name><name><surname>Sindermann</surname><given-names>JR</given-names></name><name><surname>Scheld</surname><given-names>HH</given-names></name><name><surname>Martens</surname><given-names>S</given-names></name></person-group>. <article-title>Cardiac tumors--diagnosis and surgical treatment.</article-title> <source>Dtsch Arztebl Int</source>. <year>2014</year> March 21;<volume>111</volume>(<issue>12</issue>):<fpage>205</fpage>&#x2013;<lpage>11</lpage>. <pub-id pub-id-type="doi">10.3238/arztebl.2014.0205</pub-id><pub-id pub-id-type="pmid">24717305</pub-id></mixed-citation></ref>
</ref-list>
</back>
</article>
